Project Grant R21TW012889

Award Date 8/19/24
Completion Date 6/30/26
Dollars Obligated $362K
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
Uganda
Similar Awards
The Fogarty International Center (FIC), part of the U.S. Department of Health and Human Services National Institutes of Health, awarded a $268,665 Project Grant (CFDA 93.989 - International Research and Research Training) to the Joint Clinical Research Centre in Uganda. The grant, titled "LEVERAGING NORTH-SOUTH PARTNERSHIPS TO ADVANCE CELL AND GENE THERAPY FOR HIV RESEARCH TRAINING CAPACITY IN UGANDA (C AND GT-UGANDA)," aims to build research and training capacity for cell and gene...
The federal Project Grant award of $101,290 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to strengthen grants administration capacity at the Makerere University College of Health Sciences in Uganda. The key products and services to be delivered under this award include: Providing advanced training and mentorship to senior research administrators at Makerere University on best practices for pre- and post-award...
The Fogarty International Center (FIC) of the National Institutes of Health (NIH) awarded a $100,987 Project Grant under the International Research and Research Training program (CFDA 93.989) to Mu-Jhu Care LTD, a non-profit organization in Uganda. The three-year grant, awarded on May 19, 2025 and concluding on Feb 29, 2028, aims to strengthen the research compliance and integrity (RCI) capacity of the Makerere University-Johns Hopkins University (MU-JHU) Research Collaboration and other...
This $100,720 Project Grant awarded by the Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to strengthen the capacity of the African Center of Excellence in Bioinformatics and Data Intensive Sciences (ACE) in Uganda to support HIV research. The grant will fund the training of four local staff in high-performance computing (HPC) competencies at the Texas Advanced Computing Center, enabling them to implement HPC system improvements and integrate HPC...
This Project Grant award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), supports a comprehensive study to determine the prevalence and clinical characteristics of mild cognitive impairment (MCI) and Alzheimer's-related dementia (ADRD) among older adults living with HIV in Uganda. The $1,103,953 award, which began on Sep 15, 2024 and runs through Aug 31, 2025, will fund the following key activities: Comprehensive neuropsychological assessments among 600 older...
This federal Project Grant award of $302,142, provided by the Fogarty International Center (CFDA 93.989 - International Research and Research Training program), is intended to strengthen the capacity of researchers in Uganda to conduct HIV treatment and prevention clinical trials focused on perinatal, pediatric, adolescent, and high-risk populations, including women and their partners. The awardee, Mu-Jhu Care LTD, an international organization based in Kampala, Uganda, will serve as a...
The U.S. Department of Health and Human Services, through the Fogarty International Center's International Research and Research Training program (CFDA 93.989), awarded a $749,200 Project Grant to the Regents of the University of Minnesota. This 5-year grant, effective August 14, 2024, supports the Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium in Uganda. The program aims to expand research expertise in neuro-infectious diseases by training at least 12 physician...
This Project Grant awarded by the Fogarty International Center (CFDA 93.989 - International Research and Research Training) supports research to determine the prevalence and risk factors for persistent neurological deficits after cryptococcal meningitis among HIV patients in Uganda. The $347,374 award to the Infectious Diseases Institute Limited in Kampala, Uganda will fund a cohort study to assess long-term neurocognitive outcomes, chronic inflammation, and persistent cryptococcal antigenemia...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $615,891 to conduct a multi-year study on sepsis pathobiology in sub-Saharan Africa (SSA). The primary awardee, The Trustees of Columbia University, will lead a team to validate the presence of distinct sepsis "endotypes" in Uganda that reflect host-pathogen features unique to the region. They will...
This Project Grant award of $646,561 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a study to evaluate the impact of a peer-navigation strategy on improving tuberculosis (TB) and HIV treatment adherence and outcomes among individuals in Uganda. The study aims to adapt and implement a multi-component peer-led TB education and adherence counseling intervention, and conduct a cluster-randomized trial to assess...

The National Institutes of Health (NIH) Fogarty International Center (CFDA 93.989) awarded a $361,922 Project Grant to Makerere University College of Health Sciences in Uganda to establish a registry and research platform focused on the intersection of HIV and rheumatic/musculoskeletal diseases (RMDs). The 2-year project aims to collect epidemiological and clinical data on patients with co-morbid HIV and RMDs, in order to advance research on this important but underrecognized issue in sub-Saharan Africa. As part of the project, the researchers will conduct a demonstration study on patients with HIV and rheumatoid arthritis to illustrate the feasibility of the new research platform. The grant funding will support capacity building, infrastructure development, and collaborative research between Makerere University and Yale University to better understand the burden, biology, and progression of RMDs among people living with HIV in Uganda.

Generated 8/5/25, 5:22 AM